Insulin aspart, recombinant Subcutaneous and Sevelamer Suspension
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Sevelamer Suspension and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: sevelamer
Brand name: Renagel, Renvela
Synonyms: Sevelamer
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Sevelamer Tablets
- Insulin aspart, recombinant Subcutaneous-Severent
- Insulin aspart, recombinant Subcutaneous-Severent Diskhaler
- Insulin aspart, recombinant Subcutaneous-Severent Diskus
- Insulin aspart, recombinant Subcutaneous-Sevoflurane
- Insulin aspart, recombinant Subcutaneous-Sevoflurane Inhalation, oral/nebulization
- Sevelamer Suspension-Insulin degludec
- Sevelamer Suspension-Insulin Degludec (U-100) Prefilled Pens
- Sevelamer Suspension-Insulin Degludec (U-100) Vials
- Sevelamer Suspension-Insulin Degludec (U-200) Prefilled Pens
- Sevelamer Suspension-Insulin degludec and liraglutide
- Sevelamer Suspension-Insulin degludec and liraglutide Subcutaneous